No disease recurrences after short course of neoadjuvant immunotherapy, according to follow-up
A short course of neoadjuvant immunotherapy continues to show long-term outcomes in patients with locally advanced mismatch repair–deficient (dMMR) colon cancer. In the NICHE-2 study, none of the 111 patients in the primary ...
Oct 22, 2026
0
8









